Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy

被引：0
|
作者：
Soroush Moallef
Kora DeBeck
Nadia Fairbairn
Zishan Cui
Rupinder Brar
Dean Wilson
Cheyenne Johnson
M.-J. Milloy
Kanna Hayashi
机构：
[1] British Columbia Centre on Substance Use,School of Public Policy
[2] St. Paul’s Hospital,Department of Medicine
[3] Simon Fraser University,School of Nursing
[4] University of British Columbia,Faculty of Health Sciences
[5] Vancouver Coastal Health Authority,undefined
[6] University of British Columbia,undefined
[7] Simon Fraser University,undefined
来源：
Addiction Science & Clinical Practice | / 17卷
关键词：
COVID-19; Opioid agonist therapy; Medication for opioid use disorder; Overdose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy
    Moallef, Soroush
    DeBeck, Kora
    Fairbairn, Nadia
    Cui, Zishan
    Brar, Rupinder
    Wilson, Dean
    Johnson, Cheyenne
    Milloy, M. -J.
    Hayashi, Kanna
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [2] A Cross-sectional Study of Opioid Agonist Therapy Barriers and Facilitators
    Duff, Elsie
    Fehr, Cindy
    Shams, Shahid
    Wintoniw, Steven
    Devenney, Ashley
    Ashfield, Diana
    O'Rourke, Tammy
    [J]. JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (04):
  • [3] Trajectories of retention in opioid agonist therapy in a Canadian setting
    Socias, M. Eugenia
    Dong, Huiru
    Wood, Evan
    Brar, Rupinder
    Richardson, Lindsey
    Hayashi, Kanna
    Kerr, Thomas
    Milloy, M-J
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 77
  • [4] Opioid Agonist Treatment Modifications During COVID-19 Pandemic
    Sproule, Beth
    Stovel, Jessica
    Saragosa, Julia
    Huynh, Helen
    Di Paola, Francesca
    Brands, Bruna
    Zhang, Maria
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [5] Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
    Aldabergenov, D.
    Reynolds, L.
    Scott, J.
    Kelleher, M. J.
    Strang, J.
    Copeland, C. S.
    Kalk, N. J.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 110
  • [6] Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting
    Dong, Huiru
    Hayashi, Kanna
    Milloy, M-J
    DeBeck, Kora
    Singer, Joel
    Wong, Hubert
    Wood, Evan
    Kerr, Thomas
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 212
  • [7] Real-world Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients with Opioid Use Disorder during the COVID-19 Pandemic
    Lee, Kenneth
    Zhao, Yue
    Merali, Tazmin
    Fraser, Christopher
    Kozicky, Jan-Marie
    Mormont, Marie-Christine
    Conway, Brian
    [J]. JOURNAL OF ADDICTION MEDICINE, 2023, 17 (06) : E374 - E381
  • [8] People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study
    Conway, Anna
    Treloar, Carla
    Crawford, Sione
    Grebely, Jason
    Marshall, Alison D.
    [J]. DRUG AND ALCOHOL REVIEW, 2023, 42 (01) : 203 - 212
  • [9] Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
    von Bernuth, Kira
    Seidel, Peter
    Krebs, Julia
    Lehmann, Marc
    Neumann, Britta
    Konrad, Norbert
    Opitz-Welke, Annette
    [J]. FRONTIERS IN PSYCHIATRY, 2020, 11
  • [10] The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
    Mackay, Lindsay
    Kerr, Thomas
    Fairbairn, Nadia
    Grant, Cameron
    Milloy, M. -J.
    Hayashi, Kanna
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
12345